2012 Q2 Form 10-Q Financial Statement

#000031314312000135 Filed on August 08, 2012

View on sec.gov

Income Statement

Concept 2012 Q2 2011 Q3
Revenue $176.5M $170.6M
YoY Change 3.79% 4.62%
Cost Of Revenue $86.36M $81.82M
YoY Change 4.68% 6.85%
Gross Profit $90.11M $88.75M
YoY Change 2.99% 2.64%
Gross Profit Margin 51.06% 52.03%
Selling, General & Admin $67.63M $56.23M
YoY Change 40.59% 3.45%
% of Gross Profit 75.04% 63.36%
Research & Development $9.409M $8.609M
YoY Change 6.92% 8.7%
% of Gross Profit 10.44% 9.7%
Depreciation & Amortization $11.20M $12.00M
YoY Change 0.9% -3.23%
% of Gross Profit 12.43% 13.52%
Operating Expenses $77.03M $64.84M
YoY Change 35.38% 4.12%
Operating Profit $13.08M $23.91M
YoY Change -54.74% -1.16%
Interest Expense $300.0K -$200.0K
YoY Change -200.0% -230.72%
% of Operating Profit 2.29% -0.84%
Other Income/Expense, Net $336.0K -$215.0K
YoY Change -190.72%
Pretax Income $13.42M $23.69M
YoY Change -53.09% -2.8%
Income Tax $3.628M $6.746M
% Of Pretax Income 27.04% 28.47%
Net Earnings $9.787M $16.95M
YoY Change -53.37% -5.42%
Net Earnings / Revenue 5.55% 9.94%
Basic Earnings Per Share $0.19 $0.33
Diluted Earnings Per Share $0.19 $0.32
COMMON SHARES
Basic Shares Outstanding 50.97M shares 25.73M shares
Diluted Shares Outstanding 51.86M shares 26.22M shares

Balance Sheet

Concept 2012 Q2 2011 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $236.0M $216.9M
YoY Change 19.98% 159.76%
Cash & Equivalents $236.0M $216.9M
Short-Term Investments
Other Short-Term Assets $51.20M $35.60M
YoY Change 26.11% 18.97%
Inventory $126.8M $94.96M
Prepaid Expenses
Receivables $126.1M $120.8M
Other Receivables $0.00 $0.00
Total Short-Term Assets $540.2M $468.3M
YoY Change 20.35% 44.74%
LONG-TERM ASSETS
Property, Plant & Equipment $166.2M $157.0M
YoY Change 6.89% -0.25%
Goodwill $115.0M $115.7M
YoY Change -0.28% -1.73%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $11.08M $10.20M
YoY Change 5.94% 9.38%
Total Long-Term Assets $387.9M $385.1M
YoY Change 0.91% 2.96%
TOTAL ASSETS
Total Short-Term Assets $540.2M $468.3M
Total Long-Term Assets $387.9M $385.1M
Total Assets $928.1M $853.4M
YoY Change 11.38% 22.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $33.98M $28.16M
YoY Change 19.97% 20.23%
Accrued Expenses $25.20M $23.00M
YoY Change -6.67% -8.73%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $2.417M $906.0K
YoY Change 164.73% -85.88%
Total Short-Term Liabilities $121.9M $103.0M
YoY Change 12.18% 0.99%
LONG-TERM LIABILITIES
Long-Term Debt $2.642M $3.606M
YoY Change -33.38% -17.75%
Other Long-Term Liabilities $21.75M $15.94M
YoY Change 37.48% 25.21%
Total Long-Term Liabilities $24.39M $19.55M
YoY Change 23.28% 14.2%
TOTAL LIABILITIES
Total Short-Term Liabilities $121.9M $103.0M
Total Long-Term Liabilities $24.39M $19.55M
Total Liabilities $146.3M $122.6M
YoY Change 13.89% 2.89%
SHAREHOLDERS EQUITY
Retained Earnings $410.6M $390.6M
YoY Change 9.89% 25.36%
Common Stock $341.7M $310.3M
YoY Change 12.77% 23.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $757.5M $712.5M
YoY Change
Total Liabilities & Shareholders Equity $928.1M $853.4M
YoY Change 11.38% 22.34%

Cashflow Statement

Concept 2012 Q2 2011 Q3
OPERATING ACTIVITIES
Net Income $9.787M $16.95M
YoY Change -53.37% -5.42%
Depreciation, Depletion And Amortization $11.20M $12.00M
YoY Change 0.9% -3.23%
Cash From Operating Activities $553.0K $27.13M
YoY Change -98.28% 100.58%
INVESTING ACTIVITIES
Capital Expenditures $8.441M $11.80M
YoY Change -172.15% -22.48%
Acquisitions
YoY Change
Other Investing Activities -$700.0K $0.00
YoY Change -163.64% -100.0%
Cash From Investing Activities -$9.189M -$11.78M
YoY Change -13.31% -22.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $217.0K $361.0K
YoY Change
Cash From Financing Activities $16.23M $4.467M
YoY Change 295.78% -108.13%
NET CHANGE
Cash From Operating Activities $553.0K $27.13M
Cash From Investing Activities -$9.189M -$11.78M
Cash From Financing Activities $16.23M $4.467M
Net Change In Cash $7.591M $19.82M
YoY Change -70.46% -135.06%
FREE CASH FLOW
Cash From Operating Activities $553.0K $27.13M
Capital Expenditures $8.441M $11.80M
Free Cash Flow -$7.888M $15.33M
YoY Change -117.97% -1002.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
35425000 USD
CY2012Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
33978000 USD
CY2012Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
126130000 USD
CY2012Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
135464000 USD
CY2012Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
8075000 USD
CY2012Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
8080000 USD
CY2012Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
351915000 USD
CY2012Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
348877000 USD
CY2012Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5241000 USD
CY2012Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
9110000 USD
CY2012Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
341401000 USD
CY2012Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
322485000 USD
CY2012Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2400000 USD
CY2011Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1480000 USD
CY2011Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1399000 USD
CY2011Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
500000 shares
CY2012Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
400000 shares
CY2012Q2 us-gaap Assets
Assets
928123000 USD
CY2012Q1 us-gaap Assets
Assets
911135000 USD
CY2012Q1 us-gaap Assets Current
AssetsCurrent
527129000 USD
CY2012Q2 us-gaap Assets Current
AssetsCurrent
540187000 USD
CY2012Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
202911000 USD
CY2011Q4 us-gaap Average Remaining Maturity Of Foreign Currency Derivatives
AverageRemainingMaturityOfForeignCurrencyDerivatives
one
CY2012Q2 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">BASIS OF PRESENTATION</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles (&#8220;GAAP&#8221;) in the United States for interim financial information and with the instructions to Form 10-Q and Article&#160;10 of Regulation&#160;S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of our management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. All significant intercompany transactions have been eliminated. Certain reclassifications were made to prior year balances to conform to the presentation of the financial statements for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2012</font><font style="font-family:inherit;font-size:10pt;">. Operating results for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;"> month period ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2012</font><font style="font-family:inherit;font-size:10pt;"> are not necessarily indicative of the results that may be expected for the full fiscal year ending </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;30, 2013</font><font style="font-family:inherit;font-size:10pt;">, or any other interim period. These unaudited consolidated financial statements should be read in conjunction with our audited consolidated financial statements and footnotes included in our annual report on Form 10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2012</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our fiscal year ends on the Saturday closest to the last day of March. Fiscal years </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2012</font><font style="font-family:inherit;font-size:10pt;"> include </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">52</font><font style="font-family:inherit;font-size:10pt;">&#160;weeks with each quarter having </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">13</font><font style="font-family:inherit;font-size:10pt;">&#160;weeks.</font></div></div>
CY2011Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability
-89000 USD
CY2012Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability
0 USD
CY2012Q2 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
17400000 USD
CY2012Q1 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
15400000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
228861000 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
236047000 USD
CY2011Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
216891000 USD
CY2011Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
196707000 USD
CY2012Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
7186000 USD
CY2011Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
20184000 USD
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2011Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2011Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2011Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25301899 shares
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25638171 shares
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25638171 shares
CY2011Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25301899 shares
CY2012Q2 us-gaap Common Stock Value
CommonStockValue
256000 USD
CY2012Q1 us-gaap Common Stock Value
CommonStockValue
253000 USD
CY2011Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
18945000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5918000 USD
CY2012Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
86362000 USD
CY2011Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
81821000 USD
CY2012Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
10579000 USD
CY2012Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
9665000 USD
CY2012Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
23000 USD
CY2012Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
656000 USD
CY2012Q1 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
64000 USD
CY2012Q2 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
297000 USD
CY2012Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
23332000 USD
CY2012Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
24356000 USD
CY2011Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
11988000 USD
CY2012Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
11180000 USD
CY2012Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
6186000 USD
CY2012Q2 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
4756000 USD
CY2012Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
1185000 USD
CY2012Q2 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
1808000 USD
CY2011Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.66
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.38
CY2011Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
CY2012Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-405000 USD
CY2011Q3 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
368000 USD
CY2012Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.270
CY2011Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.285
CY2012Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
29451000 USD
CY2012Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
25162000 USD
CY2012Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
800000 USD
CY2012Q2 us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
2105000 USD
CY2011Q3 us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
1849000 USD
CY2012Q2 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1111000 USD
CY2011Q3 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
313000 USD
CY2011Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
57710000 USD
CY2011Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
54973000 USD
CY2012Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
96549000 USD
CY2012Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
94913000 USD
CY2012Q1 us-gaap Foreign Currency Cash Flow Hedge Derivative At Fair Value Net
ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet
162100000 USD
CY2012Q2 us-gaap Foreign Currency Cash Flow Hedge Derivative At Fair Value Net
ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet
147600000 USD
CY2012Q2 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
4756000 USD
CY2012Q2 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
1808000 USD
CY2012Q1 us-gaap Foreign Currency Derivative Instruments Not Designated As Hedging Instruments At Fair Value Net
ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet
45500000 USD
CY2012Q2 us-gaap Foreign Currency Derivative Instruments Not Designated As Hedging Instruments At Fair Value Net
ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet
55400000 USD
CY2012Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-110000 USD
CY2011Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-56000 USD
CY2012Q2 us-gaap Goodwill
Goodwill
115048000 USD
CY2012Q1 us-gaap Goodwill
Goodwill
115058000 USD
CY2012Q2 us-gaap Gross Profit
GrossProfit
90113000 USD
CY2011Q3 us-gaap Gross Profit
GrossProfit
88748000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
13415000 USD
CY2011Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
23693000 USD
CY2011Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-7939000 USD
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3628000 USD
CY2011Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6746000 USD
CY2012Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3194000 USD
CY2011Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1387000 USD
CY2011Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-7900000 USD
CY2012Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-9605000 USD
CY2012Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8020000 USD
CY2012Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
17040000 USD
CY2011Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
10288000 USD
CY2012Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
5479000 USD
CY2011Q3 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
3059000 USD
CY2011Q3 us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-7993000 USD
CY2012Q2 us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
455000 USD
CY2012Q2 us-gaap Interest Paid Net
InterestPaidNet
84000 USD
CY2011Q3 us-gaap Interest Paid Net
InterestPaidNet
102000 USD
CY2012Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
71304000 USD
CY2012Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
79199000 USD
CY2012Q2 us-gaap Inventory Net
InventoryNet
126843000 USD
CY2012Q1 us-gaap Inventory Net
InventoryNet
117163000 USD
CY2012Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
43493000 USD
CY2012Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
41219000 USD
CY2012Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
4151000 USD
CY2012Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
4640000 USD
CY2012Q2 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
198155000 USD
CY2012Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
911135000 USD
CY2012Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
928123000 USD
CY2012Q2 us-gaap Liabilities Current
LiabilitiesCurrent
121906000 USD
CY2012Q1 us-gaap Liabilities Current
LiabilitiesCurrent
130744000 USD
CY2012Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1808000 USD
CY2012Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
2417000 USD
CY2012Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
894000 USD
CY2012Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2877000 USD
CY2012Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2642000 USD
CY2012Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
137877000 USD
CY2012Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
136057000 USD
CY2011Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4467000 USD
CY2012Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16227000 USD
CY2012Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9189000 USD
CY2011Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11782000 USD
CY2012Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
553000 USD
CY2011Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
27131000 USD
CY2011Q3 us-gaap Net Income Loss
NetIncomeLoss
16947000 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
9787000 USD
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
77034000 USD
CY2011Q3 us-gaap Operating Expenses
OperatingExpenses
64840000 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
13079000 USD
CY2011Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
23908000 USD
CY2012Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11079000 USD
CY2012Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10719000 USD
CY2012Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
56835000 USD
CY2012Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
51972000 USD
CY2012Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
21752000 USD
CY2012Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
21551000 USD
CY2012Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
336000 USD
CY2011Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-215000 USD
CY2012Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8441000 USD
CY2011Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11801000 USD
CY2012Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
35976000 USD
CY2012Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
40588000 USD
CY2012Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1000000 USD
CY2011Q3 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
CY2012Q2 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-18000 USD
CY2011Q3 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-9000 USD
CY2012Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
252000 USD
CY2011Q3 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
19000 USD
CY2012Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
13246000 USD
CY2011Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2675000 USD
CY2012Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
796000 USD
CY2011Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1259000 USD
CY2011Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1273000 USD
CY2012Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
642000 USD
CY2011Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
292000 USD
CY2012Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
437000 USD
CY2011Q3 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
278000 USD
CY2012Q2 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
283000 USD
CY2012Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
510534000 USD
CY2012Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
518155000 USD
CY2012Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
166240000 USD
CY2012Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
161657000 USD
CY2012Q1 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
226476000 USD
CY2012Q2 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
229763000 USD
CY2011Q3 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
361000 USD
CY2012Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
217000 USD
CY2011Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8609000 USD
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9409000 USD
CY2011Q3 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
1500000 USD
CY2012Q2 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
1900000 USD
CY2012Q1 us-gaap Restructuring Reserve
RestructuringReserve
1994000 USD
CY2012Q2 us-gaap Restructuring Reserve
RestructuringReserve
1131000 USD
CY2012Q2 us-gaap Restructuring Reserve Period Expense
RestructuringReservePeriodExpense
805000 USD
CY2012Q2 us-gaap Restructuring Reserve Settled With Cash
RestructuringReserveSettledWithCash
1668000 USD
CY2012Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
410569000 USD
CY2012Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
400783000 USD
CY2012Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
176475000 USD
CY2011Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
170569000 USD
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
67625000 USD
CY2011Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
56231000 USD
CY2011Q3 us-gaap Share Based Compensation
ShareBasedCompensation
2401000 USD
CY2012Q2 us-gaap Share Based Compensation
ShareBasedCompensation
2417000 USD
CY2011Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm
4.9 Year
CY2011Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm
4.9 Year
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.2791
CY2011Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.2720
CY2011Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0165
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0092
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
17.36
CY2011Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
17.68
CY2011Q3 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
41067 shares
CY2012Q2 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
42257 shares
CY2012Q1 us-gaap Stockholders Equity
StockholdersEquity
732631000 USD
CY2012Q2 us-gaap Stockholders Equity
StockholdersEquity
757467000 USD
CY2012Q2 us-gaap Tax Benefit From Stock Options Exercised
TaxBenefitFromStockOptionsExercised
1050000 USD
CY2011Q3 us-gaap Tax Benefit From Stock Options Exercised
TaxBenefitFromStockOptionsExercised
356000 USD
CY2012Q2 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-568000 USD
CY2011Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-609000 USD
CY2011Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
485000 shares
CY2012Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
449000 shares
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25932000 shares
CY2011Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26216000 shares
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25483000 shares
CY2011Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25731000 shares
CY2012Q1 hae Land Building And Building Improvements
LandBuildingAndBuildingImprovements
59816000 USD
CY2012Q2 hae Land Building And Building Improvements
LandBuildingAndBuildingImprovements
55533000 USD
CY2012Q1 hae Office Equipment And Information Technology
OfficeEquipmentAndInformationTechnology
88185000 USD
CY2012Q2 hae Office Equipment And Information Technology
OfficeEquipmentAndInformationTechnology
94982000 USD
CY2011Q3 hae Stock Issued During Period Employee Stock Purchase Plans Price Per Share
StockIssuedDuringPeriodEmployeeStockPurchasePlansPricePerShare
46.80
CY2012Q2 hae Stock Issued During Period Employee Stock Purchase Plans Price Per Share
StockIssuedDuringPeriodEmployeeStockPurchasePlansPricePerShare
49.83
CY2012Q2 hae Term Of Each Fiscal Quarter
TermOfEachFiscalQuarter
P1Y
CY2012 hae Term Of Each Fiscal Quarter
TermOfEachFiscalQuarter
P1Y
CY2012Q2 hae Term Of Each Quarter
TermOfEachQuarter
P3M
CY2012 hae Term Of Each Quarter
TermOfEachQuarter
P3M
CY2012Q2 hae Total Other Assets
TotalOtherAssets
221696000 USD
CY2012Q1 hae Total Other Assets
TotalOtherAssets
222349000 USD
CY2012Q2 hae Transfers From Inventory To Fixed Assets
TransfersFromInventoryToFixedAssets
7236000 USD
CY2011Q3 hae Transfers From Inventory To Fixed Assets
TransfersFromInventoryToFixedAssets
3150000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2012-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000313143
CY2012Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25638171 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
HAEMONETICS CORP

Files In Submission

Name View Source Status
0000313143-12-000135-index-headers.html Edgar Link pending
0000313143-12-000135-index.html Edgar Link pending
0000313143-12-000135.txt Edgar Link pending
0000313143-12-000135-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
hae-20120630.xml Edgar Link completed
hae-20120630.xsd Edgar Link pending
hae-20120630_cal.xml Edgar Link unprocessable
hae-20120630_def.xml Edgar Link unprocessable
hae-20120630_lab.xml Edgar Link unprocessable
hae-20120630_pre.xml Edgar Link unprocessable
hae20120630exh311.htm Edgar Link pending
hae20120630exh312.htm Edgar Link pending
hae20120630exh321.htm Edgar Link pending
hae20120630exh322.htm Edgar Link pending
hae20120630q1.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending